.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
The Government of India plans to introduce a national registry to monitor implantable medical devices and patients. Consequently, this initiative aims to enhance clinical accountability and limit the overuse of uncertified products.
Historically, healthcare providers could not easily trace faulty implants during global recalls. However, the proposed National Implant Registry will resolve this issue by ensuring comprehensive end-to-end tracking. Initially, the project will mandate strict data logging for cardiac and orthopaedic implants. Manufacturers, suppliers, and hospitals must maintain detailed records in this first phase. Ultimately, the system will expand to cover all high-risk devices used nationwide.
Furthermore, the registry will help block low-quality and cheap imports from neighbouring countries. Therefore, Indian hospitals will rely more on certified and safe hardware. Additionally, collected data will help guide national procurement policies. This database will also assist in building robust, localized clinical evidence for future medical treatments. Currently, India implants over one million high-risk medical devices annually, including pacemakers and artificial joints.
Q1: Which devices will be tracked in the initial phase?
The first phase will strictly focus on cardiac and orthopaedic implants, such as pacemakers, stents, and joint replacements.
Q2: How does the registry protect patients during global recalls?
Because the registry logs patient-device linkages, hospitals can rapidly locate and notify patients if a recall occurs.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or replace professional judgment. Refer to the latest local and national guidelines for clinical practice.
References
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
India is launching a national registry to track implantable medical devices and patients, enhancing accountability and safety during global product recalls....
3 months ago
Explore the emerging role of Brixadi, an extended-release buprenorphine injection, for managing stimulant use disorder through kappa opioid receptor antagonism and steady plasma levels.
Today
A premature neonate developed upper limb compartment syndrome after uterine rupture extruded the arm through a scar defect. Conservative management with continuous monitoring yielded complete functional recovery and normal limb growth at 10-year follow-up, highlighting non-operative safety in selected cases.
Today
Dendritic cells bridge innate and adaptive immunity in myocardial infarction. This review explores their pathological roles, circulating dynamics, novel tolerogenic interventions, and how standard cardiovascular medications modulate dendritic cells to improve post-infarction myocardial repair and patient outcomes.
Today
Endoscopic posterior cervical fusion combines minimally invasive decompression, joint preparation, and rigid screw-rod fixation for atlantoaxial pathologies. Early clinical findings demonstrate solid bony union, excellent symptom relief, and minimal soft-tissue morbidity without significant vascular compromise.
Yesterday
Atherosclerosis involves extensive glycometabolic reprogramming across immune and vascular cells. This review examines how glycolysis, the pentose phosphate pathway, and lactate-driven epigenetic shifts fuel plaque vulnerability, while highlighting novel therapeutic targets like PFKFB3 and LDHA.
Today
